SCHEMBL2286052

SCHEMBL2286052

[CH]1CCC2C(C1)CCC1C3CCCC3CCC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8931389 1.00
SCHEMBL18740462 1.00
SCHEMBL8922105 0.95 ALDH1A1 (0.30)
SCHEMBL4421790 0.83
SCHEMBL6024965 0.83
SCHEMBL4421794 0.83
SCHEMBL15823164 0.81
SCHEMBL3003480 0.80 ALDH1A1 (0.38)
SCHEMBL29885718 0.77 ALDH1A1 (0.44)
SCHEMBL29886257 0.77 ALDH1A1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10766920-B2 Certain chemical entities, compositions, and methods NEUPHARMA, INC. (US) 2020-09-08 US disclosed
US-20200024303-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. 2020-01-23 US disclosed
US-10344048-B2 Certain chemical entities, compositions, and methods NEUPHARMA, INC. (US) 2019-07-09 US disclosed
US-20170088580-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. 2017-03-30 US disclosed
US-9493503-B2 Certain chemical entities, compositions, and methods NEUPHARMA, INC. (US) 2016-11-15 US disclosed
EP-2523966-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Suzhou Neupharma Co., Ltd (CN) 2012-11-21 EP disclosed
US-20120196842-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. 2012-08-02 US disclosed
WO-2011085641-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS SUZHOU NEUPHARMA CO., LTD. (CN) 2011-07-21 WO disclosed